Who
In numbers
- Trades disclosed
- 17
- Buys
- 1
- Sells
- 0
- Bought
- $199K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 10 Mar 2025
- Last trade
- 9 Jul 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 28 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —18,400 at $0.00 | filing |
| 9 Jul 2026filed 28 Aug 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —18,400 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Code A | —21,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,400 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $1,3084,229 at $0.3094 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $23K77,148 at $0.3003 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $28K86,947 at $0.3174 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $24K78,116 at $0.3114 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $23K77,417 at $0.3016 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $1,3114,229 at $0.31 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $23K77,148 at $0.30 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $28K86,947 at $0.32 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $24K78,116 at $0.31 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CUE Cue BiopharmaBiotechnology | SEC FORM 4 Bought | $23K77,417 at $0.30 | filing |
| 10 Mar 2025filed 12 Mar 2025 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,800 at $0.00 | filing |
News
Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 SharesCUE · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in StockCUE · themarketsdaily.com · 15 Oct 2026Contrasting Cue Biopharma (NASDAQ:CUE) & REGENXBIO (NASDAQ:RGNX)CUE · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Pasha Sarraf; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.